Stock listing

PCRX Stock Price, News, Filings & Events — Pacira Biosciences, Inc.

Selected listing: PCRX · BOATS · USD · US

This page tracks Pacira Biosciences, Inc.'s PCRX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PCRX:BOATS. PCRX:BOATS is the stock-level entry point for investors researching Pacira Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pacira Biosciences, Inc. is a public company traded under the ticker PCRX in the American market. The company has a market capitalization of approximately $1.01 billion. Pacira focuses on developing and commercializing innovative non-opioid pain management solutions.

PCRX:BOATSUSDUSUpdated August 28, 2026
Pacira Biosciences, Inc. logo
Ticker
PCRX:BOATS
Asset type
Stock
Market cap
$1.03B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Pacira Biosciences, Inc. PCRX:BOATS stock context

This page tracks Pacira Biosciences, Inc.'s PCRX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PCRX:BOATS. PCRX:BOATS is the stock-level entry point for investors researching Pacira Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pacira Biosciences, Inc. is a public company traded under the ticker PCRX in the American market. The company has a market capitalization of approximately $1.01 billion. Pacira focuses on developing and commercializing innovative non-opioid pain management solutions.

Latest news from Pacira Biosciences, Inc.

All Pacira Biosciences, Inc. news →

Pacira Biosciences, Inc. earnings calls

Research Pacira Biosciences, Inc.

Alternate listings